Related Experiment Video
Updated: Jul 16, 2025

09:19
Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
Published on: July 6, 2022
5.0K
Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression
Yan Wang1, Bing Liu2, Qingjie Min1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Cell Discovery
|September 18, 2023
Summary
This study reveals molecular drivers of lung adenocarcinoma (LUAD) histologic subtype progression. It identifies unique macrophage populations and hypoxia-driven networks, offering new therapeutic targets for invasive LUAD.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Lung adenocarcinoma (LUAD) exhibits coexisting indolent and aggressive histologic subtypes.
- The molecular basis for subtype transitions and heterogeneity in LUAD remains largely unknown.
Purpose of the Study:
- To elucidate the molecular characteristics and cellular plasticity of distinct LUAD histologic subtypes.
- To identify molecular drivers and signaling pathways associated with LUAD subtype progression.
Main Methods:
- Integration of spatial transcriptomics and multiplex immunohistochemistry.
- Analysis of transcriptional reprogramming and cell signaling dynamics.
Main Results:
- Distinct LUAD histologic subtypes display heterogeneity in dedifferentiation states.
- Hypoxia-induced regulatory networks significantly influence subtype progression.
- Specific tumor-associated macrophage subpopulations are identified within each LUAD subtype, potentially creating an immunosuppressive microenvironment.
Conclusions:
- A comprehensive molecular landscape of LUAD subtype progression has been established.
- The findings suggest novel therapeutic strategies and targets for invasive LUAD, particularly focusing on macrophage roles and hypoxia pathways.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K

